FGF3 AMPLIFICATION Detail (hg19) (FGF3)

Information

Genome

Assembly Position
hg19 chr11:69,624,992-69,633,792
hg38 chr11:69,810,224-69,819,024 View the variant detail on this assembly version.
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Type Database ID Link
Gene MIM 164950 OMIM
HGNC 3681 HGNC
Ensembl ENSG00000186895 Ensembl
NCBI NCBI
Gene Cards Gene Cards
OncoKB OncoKB
Type Database ID Link
Variant TogoVar
COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
breast cancer Dovitinib B Predictive Supports Sensitivity/Response N/A 2 23658459 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
81 patients were enrolled in a clinical trial with the FGFR inhibitor dovitinib. Four of these patie... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
FGF3
Genome
hg19
Position
chr11:69,624,992-69,633,792
Variant Type
cnv
Variant (CIViC) (CIViC Variant)
AMPLIFICATION
Transcript 1 (CIViC Variant)
ENST00000334134.2
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/630
Genome browser